Virtus ETF Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $117K | Sell |
|
|||||
|
2023
Q2 | $107K | Buy |
|
|||||
|
2023
Q1 | $86.2K | Sell |
|
|||||
|
2022
Q4 | $145K | Buy |
|
|||||
|
2022
Q3 | $139K | Buy |
|
|||||
|
2022
Q2 | $133K | Buy |
|
|||||
|
2022
Q1 | $92K | Sell |
|
|||||
|
2021
Q4 | $174K | Sell |
|
|||||
|
2021
Q3 | $221K | Sell |
|
|||||
|
2021
Q2 | $213K | Buy |
|
|||||
|
2021
Q1 | $219K | Buy |
|
|||||
|
2020
Q4 | $276K | Sell |
|
|||||
|
2020
Q3 | $501K | Sell |
|
|||||
|
2020
Q2 | $391K | Buy |
|
|||||
|
2020
Q1 | $247K | Sell |
|
|||||
|
2019
Q4 | $474K | Buy |
|
|||||
|
2019
Q3 | $210K | Sell |
|
|||||
|
2019
Q2 | $292K | Sell |
|
|||||
|
2019
Q1 | $477K | Sell |
|
|||||
|
2018
Q4 | $309K | Sell |
|
|||||
|
2018
Q3 | $451K | Sell |
|
|||||
|
2018
Q2 | $810K | Sell |
|
|||||
|
2018
Q1 | $1.32M | Buy |
|
|||||
|
2017
Q4 | $361K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $168K | Buy |
|